ROTHFUSS CRISTIN (EVP, General Counsel) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2025ACC: 0000950170-25-037527
Officer· EVP, General Counsel
Since Mar 2026
+24.43K
Net shares
Net buyer
$49.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
24.92K acquired · 491.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−491.00
Price / share
$100.13
Trade value
$49.16K
% of position
3.7%
3/10/2025
13.32K→12.83K
Common Stock
Direct
Shares
+8.28K
Price / share
—
Trade value
—
% of position
64.5%
3/10/2025
12.83K→21.11K
Total
Net shares
+7.79K
Net value
-$49.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2025 | F · Tax Withholding | −491.00 | $100.13 | $49.16K | 3.7% | 13.32K | 12.83K |
| Common Stock Direct | 3/10/2025 | A · Award | +8.28K | — | — | 64.5% | 12.83K | 21.11K |
| Total | +7.79K | -$49.16K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
16.64K shares
Shares
+16.64K
Strike price
99.69
Held after
16.64K
Exercisable
—
3/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock16.64K shares | 3/10/2025 | A · Award | +16.64K | 99.69 | — | 16.64K |